Novo and Anthropic partner to accelerate drug discovery

Novo and Anthropic announced a partnership to use generative AI models to accelerate drug discovery research. Advanced AIs including Claude could speed up molecular design and shortlist candidate compounds, potentially shortening traditional development timelines.

Why it mattersThe topic directly relates to shortening drug development time and increasing success probability, making investment and partnership trends important to monitor.